S. Campbell

发表

Exploiting the P-1 pocket of BRCT domains toward a structure guided inhibitor design.

Nicholas Y. Palermo, Eric A. Kumar, S. J. Campbell, 2011, ACS medicinal chemistry letters.

Insights into the recruitment of BRCA1 to double strand DNA breaks

S. J. Campbell, S. Campbell, 2012 .

Ligand binding: functional site location, similarity and docking.

S. J. Campbell, N. Gold, R. Jackson, 2003, Current opinion in structural biology.

Structure-activity relationships of boronic acid inhibitors of dipeptidyl peptidase IV. 1. Variation of the P2 position of Xaa-boroPro dipeptides.

S. J. Campbell, R. Snow, R. Barton, 1996, Journal of medicinal chemistry.

Molecular Insights into the Function of RING Finger (RNF)-containing Proteins hRNF8 and hRNF168 in Ubc13/Mms2-dependent Ubiquitylation*

S. J. Campbell, J. Glover, C. D. Hodge, 2012, The Journal of Biological Chemistry.

Visualizing the drug target landscape.

S. J. Campbell, A. Gaulton, L. Harland, 2010, Drug discovery today.

A retrospective on how the application of data integration and visualisation has been used to connect disparate information sources into a drug-discovery focused, decision making environment. Visualizing the drug target landscape

Anna Gaulton, Jason Marshall, Lee Harland, 2010 .

Comparison of the structures and peptide binding specificities of the BRCT domains of MDC1 and BRCA1.

S. J. Campbell, J. Glover, R. Edwards, 2010, Structure.

Visualizing the drug target landscape.

S. J. Campbell, A. Gaulton, L. Harland, 2012, Drug discovery today.